BLOGSCAN - FDA Panels Violate New Conflict of Interest Rules

On PharmaLot, Ed Silverman noted how the US Food and Drug Administration (FDA) seemed to violate its own new increasingly stringent rules about conflicts of interest when it set up two advisory panels which will be meeting today.